141 related articles for article (PubMed ID: 27607353)
21. Mycobacterium kansasii pulmonary diseases in Korea.
Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
[TBL] [Abstract][Full Text] [Related]
22. Mycobacterium kansasii pericarditis in a kidney transplant recipient: a case report and comprehensive review of the literature.
Cho JH; Yu CH; Jin MK; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim CD; Kim YL
Transpl Infect Dis; 2012 Oct; 14(5):E50-5. PubMed ID: 22823928
[TBL] [Abstract][Full Text] [Related]
23. Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.
Cohen JI; Dropulic L; Hsu AP; Zerbe CS; Krogmann T; Dowdell K; Hornung RL; Lovell J; Hardy N; Hickstein D; Cowen EW; Calvo KR; Pittaluga S; Holland SM
Clin Infect Dis; 2016 Jul; 63(1):41-7. PubMed ID: 27169477
[TBL] [Abstract][Full Text] [Related]
24. [Two siblings with an IL-12 and IFN-γ production disorder diagnosed with pulmonary mycobacteriosis caused by M. kansasii. Mendelian susceptibility to mycobacterial infection: an overview of literature].
Nalepa P; Strach M; Rybak-Bąk M; Siedlar M
Pneumonol Alergol Pol; 2011; 79(6):428-36. PubMed ID: 22028121
[TBL] [Abstract][Full Text] [Related]
25. Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome.
Yin SM; Ferdman RM; Wang L; Markert ML; Tam JS
J Clin Immunol; 2015 Jul; 35(5):435-8. PubMed ID: 26048260
[TBL] [Abstract][Full Text] [Related]
26. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
Marras TK; Morris A; Gonzalez LC; Daley CL
Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary
Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B
Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
[TBL] [Abstract][Full Text] [Related]
29. Disseminated Mycolicibacter arupensis and Mycobacterium avium co-infection in a patient with anti-interferon-γ neutralizing autoantibody-associated immunodeficiency syndrome.
Hirayama K; Kanda N; Suzuki T; Sasaki K; Kimura Y; Takahashi K; Matsumura M; Hatakeyama S
J Infect Chemother; 2022 Sep; 28(9):1336-1339. PubMed ID: 35691862
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience.
Lillo M; Orengo S; Cernoch P; Harris RL
Rev Infect Dis; 1990; 12(5):760-7. PubMed ID: 2237115
[TBL] [Abstract][Full Text] [Related]
31. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.
Shitrit D; Peled N; Bishara J; Priess R; Pitlik S; Samra Z; Kramer MR
Respir Med; 2008 Nov; 102(11):1598-603. PubMed ID: 18619826
[TBL] [Abstract][Full Text] [Related]
32. Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease.
Malkin J; Shrimpton A; Wiselka M; Barer MR; Duddridge M; Perera N
J Med Microbiol; 2009 Mar; 58(Pt 3):371-373. PubMed ID: 19208889
[TBL] [Abstract][Full Text] [Related]
33. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners.
Corbett EL; Churchyard GJ; Hay M; Herselman P; Clayton T; Williams B; Hayes R; Mulder D; De Cock KM
Am J Respir Crit Care Med; 1999 Jul; 160(1):10-4. PubMed ID: 10390373
[TBL] [Abstract][Full Text] [Related]
34. Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey.
Sato R; Nagai H; Matsui H; Kawabe Y; Takeda K; Kawashima M; Suzuki J; Ohshima N; Masuda K; Yamane A; Tamura A; Akagawa S; Ohta K
J Infect; 2016 Jun; 72(6):706-712. PubMed ID: 27025204
[TBL] [Abstract][Full Text] [Related]
35. Mycobacterium kansasii causing chronic monoarticular synovitis in a patient with HIV/AIDS.
Menashe L; Kerr LD; Hermann G
J Radiol Case Rep; 2015 Sep; 9(9):26-35. PubMed ID: 26629306
[TBL] [Abstract][Full Text] [Related]
36. Rituximab Treatment of Hairy Cell Leukemia in a Patient with Mycobacterium kansasii Infection: A Case Report.
Mümmler C; Zhang D; Zimmermann A; Mertsch P; Fischer L; Greither M; Khatamzas E; Ormanns S; Heiß-Neumann M; Dreyling M; von Bergwelt-Baildon M; Boeck S
Oncol Res Treat; 2021; 44(11):637-640. PubMed ID: 34547751
[TBL] [Abstract][Full Text] [Related]
37. Disseminated nontuberculous mycobacteriosis caused by mycobacterium kansasii in a patient with myelodysplastic syndrome.
Komeno T; Itoh T; Ohtani K; Kamoshita M; Hasegawa Y; Hori M; Kobayashi T; Nagasawa T; Abe T
Intern Med; 1996 Apr; 35(4):323-6. PubMed ID: 8739791
[TBL] [Abstract][Full Text] [Related]
38. Mycobacterium kansasii infection of the spine in a patient with sarcoidosis: a case report and literature review.
Bakhsh WR; Mesfin A
J Surg Orthop Adv; 2014; 23(3):162-5. PubMed ID: 25153815
[TBL] [Abstract][Full Text] [Related]
39. Disseminated cutaneous Mycobacterium kansasii infection presenting with Rosai-Dorfman disease-like histological features in a patient carrying anti-interferon-γ autoantibodies.
King YA; Hu CH; Lee YJ; Lin CF; Liu D; Wang KH
J Dermatol; 2017 Dec; 44(12):1396-1400. PubMed ID: 28836691
[TBL] [Abstract][Full Text] [Related]
40. [Mycobacterium kansasii infection in chronic thromboembolic pulmonary hypertension (CTEPH), report of two cases].
Szturmowicz M; Fijałkowska A; Rowińska-Zakrzewska E; Khalil LY; Piwek A; Kuca P; Opoka L; Augustynowicz-Kopeć E; Zwolska Z; Torbicki A
Pneumonol Alergol Pol; 2004; 72(11-12):523-9. PubMed ID: 16329355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
